Gil-Perotin S - Search Results

1

Progressive Demyelination in the Presence of Serum Myelin Oligodendrocyte Glycoprotein-IgG: A Case Report.

Gil-Perotin S, Castillo-Villalba J, Carreres-Polo J, Navarré-Gimeno A, Mallada-Frechín J, Pérez-Miralles F, Gascón F, Alcalá-Vicente C, Cubas-Nuñez L, Casanova-Estruch B. Gil-Perotin S, et al. Front Neurol. 2018 May 15;9:340. doi: 10.3389/fneur.2018.00340. eCollection 2018. Front Neurol. 2018. PMID: 29867746 Free PMC article.

2

Reducing Peripheral Inflammation with Infliximab Reduces Neuroinflammation and Improves Cognition in Rats with Hepatic Encephalopathy.

Dadsetan S, Balzano T, Forteza J, Cabrera-Pastor A, Taoro-Gonzalez L, Hernandez-Rabaza V, Gil-Perotín S, Cubas-Núñez L, García-Verdugo JM, Agusti A, Llansola M, Felipo V. Dadsetan S, et al. Front Mol Neurosci. 2016 Nov 2;9:106. doi: 10.3389/fnmol.2016.00106. eCollection 2016. Front Mol Neurosci. 2016. PMID: 27853420 Free PMC article.

3

Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis.

Casanova B, Jarque I, Gascón F, Hernández-Boluda JC, Pérez-Miralles F, de la Rubia J, Alcalá C, Sanz J, Mallada J, Cervelló A, Navarré A, Carcelén-Gadea M, Boscá I, Gil-Perotin S, Solano C, Sanz MA, Coret F. Casanova B, et al. Neurol Sci. 2017 Jul;38(7):1213-1221. doi: 10.1007/s10072-017-2933-6. Epub 2017 Apr 10. Neurol Sci. 2017. PMID: 28396953 Free PMC article.

4

Usefulness of susceptibility-weighted imaging in subacute cerebral fat embolism.

Gil-Perotin S, Carreres-Polo J. Gil-Perotin S, et al. Neurologia (Engl Ed). 2019 Nov-Dec;34(9):616-618. doi: 10.1016/j.nrl.2017.02.002. Epub 2017 Apr 17. Neurologia (Engl Ed). 2019. PMID: 28427769 Free article. English, Spanish. No abstract available.

5

In situ RT-PCR Optimized for Electron Microscopy Allows Description of Subcellular Morphology of Target mRNA-Expressing Cells in the Brain.

Cubas-Nuñez L, Duran-Moreno M, Castillo-Villalba J, Fuentes-Maestre J, Casanova B, García-Verdugo JM, Gil-Perotín S. Cubas-Nuñez L, et al. Front Cell Neurosci. 2017 May 16;11:141. doi: 10.3389/fncel.2017.00141. eCollection 2017. Front Cell Neurosci. 2017. PMID: 28559798 Free PMC article.

6

Efficacy and safety of rituximab in relapsing and progressive multiple sclerosis: a hospital-based study.

Alcalá C, Gascón F, Pérez-Miralles F, Gil-Perotín S, Navarré A, Boscá I, Coret F, Casanova B. Alcalá C, et al. J Neurol. 2018 Jul;265(7):1690-1697. doi: 10.1007/s00415-018-8899-3. Epub 2018 May 21. J Neurol. 2018. PMID: 29785523

7

Onset of secondary progressive multiple sclerosis is not influenced by current relapsing multiple sclerosis therapies.

Coret F, Pérez-Miralles FC, Gascón F, Alcalá C, Navarré A, Bernad A, Boscá I, Escutia M, Gil-Perotin S, Casanova B. Coret F, et al. Mult Scler J Exp Transl Clin. 2018 Jun 26;4(2):2055217318783347. doi: 10.1177/2055217318783347. eCollection 2018 Apr-Jun. Mult Scler J Exp Transl Clin. 2018. PMID: 30090637 Free PMC article.

8

Recurrent and universal alopecia areata following alemtuzumab treatment in multiple sclerosis: A secondary autoimmune disease.

Alcalá C, Pzére-Miralles F, Gascón F, Evole M, Estutia M, Gil-Perotín S, Casanova B. Alcalá C, et al. Mult Scler Relat Disord. 2019 Jan;27:406-408. doi: 10.1016/j.msard.2018.12.005. Epub 2018 Dec 3. Mult Scler Relat Disord. 2019. PMID: 30530069 No abstract available.

9

Chronic hyperammonemia induces peripheral inflammation that leads to cognitive impairment in rats: Reversed by anti-TNF-α treatment.

Balzano T, Dadsetan S, Forteza J, Cabrera-Pastor A, Taoro-Gonzalez L, Malaguarnera M, Gil-Perotin S, Cubas-Nuñez L, Casanova B, Castro-Quintas A, Ponce-Mora A, Arenas YM, Leone P, Erceg S, Llansola M, Felipo V. Balzano T, et al. J Hepatol. 2020 Sep;73(3):582-592. doi: 10.1016/j.jhep.2019.01.008. Epub 2019 Jan 14. J Hepatol. 2020. PMID: 30654069

10

Treatment with alemtuzumab or rituximab after fingolimod withdrawal in relapsing-remitting multiple sclerosis is effective and safe.

Alcalá C, Gascón F, Pérez-Miralles F, Domínguez JA, Gil-Perotín S, Casanova B. Alcalá C, et al. J Neurol. 2019 Mar;266(3):726-734. doi: 10.1007/s00415-019-09195-2. Epub 2019 Jan 19. J Neurol. 2019. PMID: 30661133

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

47 results

Search Page